{"id":"W4362456136","doi":"10.1158/1078-0432.ccr-22-3207","title":"SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Melanoma; Adjuvant therapy; Adjuvant; Radiation therapy; Surgery; Oncology; Gastroenterology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003172411,0.0001342682,0.0005411531,0.0003406946,0.0001455671,0.0000332943,0.0001655685,0.0001873589,0.0004785309],"category_scores_gemma":[0.002419818,0.0001101844,0.0002049061,0.0006999543,0.0003998418,0.00003314863,0.0001664606,0.0005019807,0.0000615963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001282725,"about_ca_system_score_gemma":0.0004304262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003969485,"about_ca_topic_score_gemma":0.0002451258,"domain_scores_codex":[0.997143,0.000333621,0.0006750077,0.0005298749,0.0007693308,0.000549113],"domain_scores_gemma":[0.9968764,0.001788388,0.0001012277,0.0004533288,0.0004834034,0.0002973126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.3313405,0.002038619,0.001217668,0.000319852,0.0003910749,0.0001507628,0.0002228785,0.000001782629,0.008209917,0.0003302275,0.04256298,0.6132137],"study_design_scores_gemma":[0.3356892,0.1241333,0.02444903,0.0004316379,0.000181032,0.00006704657,0.00126453,0.001556604,0.01550435,0.003628919,0.4925635,0.0005309219],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883298,0.0006026188,0.00001686024,0.004544769,0.000881338,0.002760185,0.00002800774,0.0001221813,0.002714278],"genre_scores_gemma":[0.9858605,0.00359091,0.00007123218,0.0002074643,0.001019087,0.0004329056,0.00002622728,0.00004656909,0.008745149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6126828,"threshold_uncertainty_score":0.5239578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2984597270626484,"score_gpt":0.5228688469826615,"score_spread":0.2244091199200131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}